Prescott General Partners LLC's Q3 to Q4 2022 13F Filings Summary: Changes in Holdings and Value

Prescott General Partners LLC is a hedge fund that recently released its 13F filings for the third and fourth quarters of 2022. If you’re not familiar with the term, a 13F filing is a quarterly report required by the SEC for institutional investment managers. In this report, Prescott General Partners not only discloses its portfolio holdings, but it also reveals how much money it allocates to each security.

This blog post will summarize the changes in holdings of Prescott General Partners LLC between Q3 2022 (July-Sept) and Q4 2022 (Oct-Dec) based on the above CSV file.

The CSV file shows that Prescott General Partners LLC sold some of its holdings in CREDIT ACCEP CORP MICH (CACC), reducing its shares from 1,632,368 in Q3 to 1,560,014 in Q4. The value of the shares went up from $714,977 to $740,070, which represents a 3.5% increase in value.

Prescott General Partners LLC kept its holdings in WORLD ACCEP CORP DEL (WRLD) the same between the two quarters at 2,037,495 shares. However, the value of the shares decreased from $197,270 in Q3 to $134,352 in Q4, representing a decline of 31.9%.

WAYFAIR INC (W) is another security that the hedge fund kept its holdings the same at 3,823,239 shares. The value of the shares increased slightly from $124,446 to $125,746, representing a 1% increase in value.

Prescott General Partners LLC also maintained its holdings in CIMPRESS PLC (CMPR) between Q3 and Q4, retaining 3,906,492 shares. The value of the shares went up from $95,631 to $107,858, representing a 12.8% increase in value.

However, the hedge fund reduced its holdings in YELP INC (YELP) from 2,909,751 shares in Q3 to 2,524,750 in Q4. The value of the shares went from $98,670 to $69,026, representing a decline of 30% in value.

Prescott General Partners LLC’s holdings in GLOBAL INDUSTRIAL COMPANY (GIC) remained the same between Q3 and Q4 at 1,279,677 shares. The value of the shares decreased from $34,334 to $30,110, representing a 12.3% decline in value.

In Q4, the hedge fund added GRINDR INC to its portfolio, with holdings of 4,416,557 shares. The value of the shares was $20,536.

Prescott General Partners LLC also maintained its holdings in LINEAGE CELL THERAPEUTICS IN (LCTX) at 1,851,851 shares. The value of the shares increased from $2,093 to $2,166, representing a 3.5% increase in value.

HUMACYTE INC (HUMA) is another security that the hedge fund kept its holdings the same at 568,246 shares. However, the value of the shares decreased from $1,852 to $1,198, representing a decline of 35.3% in value.

Lastly, the hedge fund reduced its holdings in AGEX THERAPEUTICS INC (AGE) from 185,185 shares in Q3 to 185,185 shares in Q4. The value of the shares went from $104 to $102, representing a decline of 1.7% in value.

One interesting change in the CSV file is that Prescott General Partners LLC completely sold its holdings in VAPOTHERM INC (VAPO) in Q4, reducing its shares from 2,557,243 in Q3 to 0 in Q4. The value of the shares went from $4,015 to $0, representing a 100% decline in value.

In summary, the CSV file shows that Prescott General Partners LLC reduced its holdings in two securities (CACC and YELP), increased its holdings in one security (CMPR), and kept its holdings the same in six securities (WRLD, W, GIC, LCTX, HUMA, and AGE) between Q3 and Q4. The hedge fund also added one security (GRINDR INC) to its portfolio and completely sold its holdings in another security (VAPO) in Q4. Overall, the value of the hedge fund's portfolio increased from $3,545,346 in Q3 to $3,337,274 in Q4, representing a decline of 5.9% in value.